Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.

@article{Marlton1995CytogeneticAC,
  title={Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.},
  author={P Marlton and Michael J Keating and Hagop M Kantarjian and Sherry A. Pierce and Susan M O'Brien and Emil J. Freireich and Elihu Estey},
  journal={Leukemia},
  year={1995},
  volume={9 6},
  pages={965-71}
}
Abnormalities of chromosome 16 in AML include del(16q), inv(16) and t(16;16). These three groups have been categorized together and have been associated with high complete remission (CR) and survival rates following Ara-C-based chemotherapy. We have reviewed the 63 AML or MDS patients with an abnormality of chromosome 16 treated at MD Anderson Cancer Center (MDACC) over the past 18 years. Marked differences in survival and remission duration (RD) were noted between the inv(16) or t(16;16… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
24 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Similar Papers

Loading similar papers…